2026 Steven J. Burden: Biology and Biochemistry Researcher – H-Index, Publications & Awards

D-Index & Metrics

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	64	9545	8810	4213	3784	135	17137

Discipline name

D-Index

World Ranking

Current World Ranking

National Ranking

Current National Ranking

Publications

Citations

Biology and Biochemistry

9545

8810

4213

3784

135

17137

Biology and Biochemistry

D-Index

Citations

17137

World Ranking

9545

National Ranking

4213

Research.com Recognitions

2013 - Fellow of the American Association for the Advancement of Science (AAAS)
1980 - Fellow of Alfred P. Sloan Foundation

Overview

Steven J. Burden is affiliated with New York University in the United States. Their research spans several domains within medicine and biochemistry, genetics, and molecular biology, with a strong focus on neurological and muscular disorders.

The main fields of study in which Steven J. Burden has contributed include:

Medicine
Biochemistry, Genetics and Molecular Biology

Subfields of particular focus are:

Neurology
Molecular Biology
Radiology, Nuclear Medicine and Imaging
Genetics
Cell Biology

Research topics frequently addressed in their work cover:

Myasthenia Gravis and Thymoma
Monoclonal and Polyclonal Antibodies Research
Peripheral Neuropathies and Disorders
Advanced biosensing and bioanalysis techniques
Neurogenetic and Muscular Disorders Research
RNA Research and Splicing
Cellular transport and secretion

Among their recent publications are the following papers:

Mechanism of disease and therapeutic rescue of Dok7 congenital myasthenia, 2021, Nature
Affinity maturation is required for pathogenic monovalent IgG4 autoantibody development in myasthenia gravis, 2020, The Journal of Experimental Medicine
The Platform Vector Gene Therapies Project: Increasing the Efficiency of Adeno-Associated Virus Gene Therapy Clinical Trial Startup, 2020, Human Gene Therapy
Activation of Muscle-Specific Kinase (MuSK) Reduces Neuromuscular Defects in the Delta7 Mouse Model of Spinal Muscular Atrophy (SMA), 2021, International Journal of Molecular Sciences
ARGX-119 is an agonist antibody for human MuSK that reverses disease relapse in a mouse model of congenital myasthenic syndrome, 2024, Science Translational Medicine

Steven J. Burden has collaborated frequently with a number of co-authors including:

Julien Oury
Casey Vieni
Rachel L. Redler
Damian C. Ekiert
Kevin C. O'Connor

Their work has appeared in multiple publication venues, notable among them are:

bioRxiv (Cold Spring Harbor Laboratory)
Nature
The Journal of Experimental Medicine
Human Gene Therapy
International Journal of Molecular Sciences

Steven J. Burden has been recognized with the following awards:

Fellow of the American Association for the Advancement of Science (AAAS), 2013
Fellow of Alfred P. Sloan Foundation, 1980

Best Publications

FoxO3 controls autophagy in skeletal muscle in vivo.

Cristina Mammucari;Giulia Milan;Vanina Romanello;Eva Masiero

2167
Citations
The Receptor Tyrosine Kinase MuSK Is Required for Neuromuscular Junction Formation In Vivo

Thomas M DeChiara;David C Bowen;David M Valenzuela;Mary V Simmons

1111
Citations
Agrin Acts via a MuSK Receptor Complex

David J Glass;David C Bowen;Trevor N Stitt;Czeslaw Radziejewski

853
Citations
Lrp4 Is a Receptor for Agrin and Forms a Complex with MuSK

Natalie Kim;Amy L. Stiegler;Thomas O. Cameron;Peter T. Hallock

720
Citations
Neuregulins and Their Receptors: A Versatile Signaling Module in Organogenesis and Oncogenesis

Steve Burden;Yosef Yarden

710
Citations
Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation

Xia Yang;Silvia Arber;Christopher William;Li Li

586
Citations
Receptor tyrosine kinase specific for the skeletal muscle lineage: Expression in embryonic muscle, at the neuromuscular junction, and after injury

David M. Valenzuela;Trevor N. Stitt;Peter S. DiStefano;Eduardo Rojas

529
Citations
Acetylcholine receptors in regenerating muscle accumulate at original synaptic sites in the absence of the nerve.

S J Burden;P B Sargent;U J McMahan

457
Citations
DNA topoisomerase IIβ and neural development

Xia Yang;Wei Li;Elizabeth D. Prescott;Steven J. Burden

434
Citations
Neuregulins are concentrated at nerve-muscle synapses and activate ACh–receptor gene expression

Sangmee Ahn Jo;Xuejun Zhu;Xuejun Zhu;Mark A. Marchionni;Steven J. Burden

376
Citations
Increased mitochondrial mass in mitochondrial myopathy mice.

Anna Wredenberg;Rolf Wibom;Hans Wilhelmsson;Caroline Graff

322
Citations
MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4

Maartje G. Huijbers;Wei Zhang;Rinse Klooster;Erik H. Niks

321
Citations
A dystroglycan mutation associated with limb-girdle muscular dystrophy.

Yuji Hara;Burcu Balci-Hayta;Takako Yoshida-Moriguchi;Motoi Kanagawa

303
Citations
The formation of neuromuscular synapses

Steven J. Burden

260
Citations
Crosslinking of proteins in acetylcholine receptor-rich membranes: Association between the β-subunit and the 43 kd subsynaptic protein

S.J. Burden;R.L. Depalma;G.S. Gottesman

257
Citations
Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses

Norihiro Yumoto;Natalie Kim;Steven J. Burden

254
Citations
Neuregulins and their receptors.

Kermit L Carraway;Steven J Burden

228
Citations
Runx1 prevents wasting, myofibrillar disorganization, and autophagy of skeletal muscle

Xiaoxia Wang;Chris Blagden;Jihua Fan;Scott J. Nowak

225
Citations
Neuregulin receptors, erbB3 and erbB4, are localized at neuromuscular synapses.

Xuejun Zhu;C. Lai;S. Thomas;S. J. Burden

225
Citations
MuSK controls where motor axons grow and form synapses

Natalie Kim;Steven J Burden

223
Citations